At a glance
- Originator Servier
- Class Antineoplastics
- Mechanism of Action Angiogenesis inhibitors; Chelating agents; Gelatinase inhibitors; Metalloprotease inhibitors; Peptide hydrolase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 06 Nov 2003 No development reported - Preclinical for Cancer in France (unspecified route)
- 02 Feb 1999 Preclinical development for Cancer in France (Unknown route)